This is an external website. DAIC is not responsible for any content on the third party website.
Andrew Weintraub, M.D., FACC, associate director, of the Interventional Cardiology and Vascular Center, medical director ...
September 20, 2019 — BioTrace Medical Inc. announced the company’s key activities at the 31st annual Transcatheter ...
May 13, 2019 — BioTrace Medical Inc. announced the company’s Tempo Lead has obtained CE Mark certification in Europe for ...
July 12, 2017 — Cardiac Insight Inc., a U.S. developer of wearable medical devices and diagnostic software, announced ...
June 20, 2017 — BioTrace Medical Inc. announced that the company’s Tempo Temporary Pacing Lead was featured in an oral ...
January 13, 2017 — BioTrace Medical Inc. announced in December the first commercial use of the company’s Tempo Temporary ...
December 19, 2016 — BioTrace Medical Inc. announced the first commercial use of the company’s Tempo Temporary Pacing ...
October 27, 2016 — BioTrace Medical Inc. said it received U.S. Food and Drug Administration (FDA) 510(k) clearance for ...